Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer

• Published in: BMC cancer Vol. 16; no. 199; p. 197
• Main Authors: Fukui, Tomoya, Itabashi, Michiko, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kasajima, Masashi, Igawa, Satoshi, Sasaki, Jiichiro, Masuda, Noriyuki
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.03.2016; BioMed Central
• Subjects: Aged; Aged, 80 and over; Analysis; Cancer therapies; Chemotherapy; Combined Modality Therapy; Confidence intervals; Data collection; Development and progression; Disease Progression; Female; Hospitals; Humans; Kaplan-Meier Estimate; Lung cancer; Lung cancer, Small cell; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lung Neoplasms - therapy; Male; Medical imaging; Medical prognosis; Metastasis; Middle Aged; Multivariate analysis; Neoplasm Metastasis; Neoplasm Staging; Patient outcomes; Prognosis; Proportional Hazards Models; Radiation therapy; Radiotherapy; Risk Factors; Small Cell Lung Carcinoma - mortality; Small Cell Lung Carcinoma - pathology; Small Cell Lung Carcinoma - therapy; Thorax - pathology; Treatment Outcome; Tumor Burden; Japan

The efficacy of combined modality therapy is evaluated for patients with extensive-stage (ES) small cell lung cancer (SCLC). This study evaluated prognostic factors affecting the risk of thoracic progression in ES-SCLC patients likely to undergo thoracic radiotherapy combined chemotherapy. A retrosp...